Evidence map›Paper›PMID 33256751›Full record

ArticleMalaria journal2020

Correction to: Mass testing and treatment for malaria followed by weekly fever screening, testing and treatment in Northern Senegal: feasibility, cost and impact.

Ruben O Conner, Yakou Dieye, Michael Hainsworth, Adama Tall, Badara Cissé, Farba Faye, Mame Demba Sy, Amadou Ba, Doudou Sene, Souleymane Ba and 13 more

Abstract readPublished Erratum
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Ruben O ConnerPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Yakou DieyePATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Michael HainsworthPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Adama TallPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Badara CisséPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Farba FayePATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Mame Demba SyProgramme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et l'Action Sociale, Dakar, Senegal.
Amadou BaPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Doudou SeneProgramme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et l'Action Sociale, Dakar, Senegal.
Souleymane BaProgramme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et l'Action Sociale, Dakar, Senegal.
Elhadji DoucouréProgramme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et l'Action Sociale, Dakar, Senegal.
Tidiane ThiamProgramme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et l'Action Sociale, Dakar, Senegal.
Moussa DiopPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Kammerle SchneiderPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Moustapha CisséProgramme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et l'Action Sociale, Dakar, Senegal.
Mady BaProgramme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et l'Action Sociale, Dakar, Senegal.
Callie A ScottPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Ritu KumarPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Elias AsfawPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Duncan EarlePATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Philippe GuinotPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Richard W SteketeePATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
Caterina GuinovartPATH Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA. cguinovart@path.org.ORCID https://orcid.org/0000-0003-0504-4486

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Identifiers

PMID33256751
PMCPMC7706200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.